Skip to main content
Equibles
AUPH logo

AUPH · Aurinia Pharmaceuticals Inc.

Track AUPH — free

Use AUPH with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$16.08 -0.04 (-0.25%) At close · Sep 4
Russell 2000 member Rebalance outlook locked
Market Cap
$2.14B
Shares
133.05M

Options Calculator

Theoretical estimate
Price contracts in your own code through the options chain API or MCP →

Estimate what a long-dated option on AUPH could return if you hold it and the stock reaches a target price. Premiums are theoretical Black-Scholes-Merton values — tune the inputs to match your broker, then compare each strike's return against simply holding the shares.

Holding period

2.00 years

Implied volatility (%)

Implied volatility from the AUPH options chain (Sep 18, 2026) — the market's own forward-looking estimate.Market-wide VIX 14.5.

Risk-free rate (%)

Latest SOFR (2026-09-03) — an overnight rate, a rough proxy over years.

Dividend per share

Annualizes to a 0% yield. No cash dividends on file — set an amount to model one.

Target price at horizon

Spot $16.08 at close 2026-09-04.

Best strike
—
Highest estimated return
Return at target
—
— annualized
Breakeven
—
Stock price to break even
Hold the stock
—
— annualized, with dividends

Return by strike at your target price

Strike ladder

Strike Moneyness Premium Breakeven Value at target Return Annualized Max loss

Per share; one contract = 100 shares. Premiums are theoretical Black-Scholes-Merton estimates — real options are American-style and priced off an implied-volatility smile, so use your broker's quote for the actual premium. Not investment advice.

Loading strategy simulator…
Key facts CIK 1600620 CUSIP 05156V102 13F (30d) 175 filings 174 filers Visit website Investor relations